Richard F. Otten

797 total citations
10 papers, 499 citations indexed

About

Richard F. Otten is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Richard F. Otten has authored 10 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 2 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in Richard F. Otten's work include Acute Myocardial Infarction Research (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Lipoproteins and Cardiovascular Health (2 papers). Richard F. Otten is often cited by papers focused on Acute Myocardial Infarction Research (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Lipoproteins and Cardiovascular Health (2 papers). Richard F. Otten collaborates with scholars based in United States and Russia. Richard F. Otten's co-authors include William J. Groh, Girish V. Nair, John C. Kincaid, Robert M. Pascuzzi, Zachary Simmons, Douglas P. Zipes, Emma Ciafaloni, Rahman Pourmand, Chandan Saha and Deepak Bhakta and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Richard F. Otten

10 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard F. Otten United States 6 269 232 182 130 48 10 499
Andrea López-López Spain 12 297 1.1× 75 0.3× 59 0.3× 82 0.6× 4 0.1× 25 513
Laura Fanning Australia 10 161 0.6× 71 0.3× 42 0.2× 162 1.2× 6 0.1× 26 446
Hailey J. Jansen Canada 15 500 1.9× 28 0.1× 126 0.7× 18 0.1× 24 668
Tianna Zhou United States 6 81 0.3× 29 0.1× 21 0.1× 20 0.2× 7 0.1× 14 232
Marnix Goethals Belgium 15 731 2.7× 97 0.4× 192 1.1× 3 0.0× 3 0.1× 29 814
Francesc Pujadas Spain 14 44 0.2× 51 0.2× 60 0.3× 160 1.2× 1 0.0× 31 446
Raymond S. Price United States 9 22 0.1× 72 0.3× 49 0.3× 214 1.6× 5 0.1× 24 429
J. H. Myers United States 13 264 1.0× 69 0.3× 99 0.5× 13 0.1× 2 0.0× 25 562
Jeff Mahon Canada 8 58 0.2× 40 0.2× 17 0.1× 43 0.3× 2 0.0× 12 275
Mitsuhiro Kitani Japan 9 94 0.3× 58 0.3× 46 0.3× 95 0.7× 32 391

Countries citing papers authored by Richard F. Otten

Since Specialization
Citations

This map shows the geographic impact of Richard F. Otten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard F. Otten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard F. Otten more than expected).

Fields of papers citing papers by Richard F. Otten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard F. Otten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard F. Otten. The network helps show where Richard F. Otten may publish in the future.

Co-authorship network of co-authors of Richard F. Otten

This figure shows the co-authorship network connecting the top 25 collaborators of Richard F. Otten. A scholar is included among the top collaborators of Richard F. Otten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard F. Otten. Richard F. Otten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Eagle, Kim A., et al.. (2015). Smoking cessation in patients with acute coronary syndrome.. PubMed. 58(1). 47–51. 1 indexed citations
2.
Saab, Fadi, Eva Kline‐Rogers, Jianming Fang, et al.. (2009). Early statin therapy in elderly patients presenting with acute coronary syndrome causing less heart failure.. PubMed. 58(4). 321–4. 6 indexed citations
3.
Groh, William J., Chandan Saha, John C. Kincaid, et al.. (2008). Electrocardiographic Abnormalities and Sudden Death in Myotonic Dystrophy Type 1. New England Journal of Medicine. 358(25). 2688–2697. 318 indexed citations
4.
Latchamsetty, Rakesh, Jianming Fang, Eva Kline‐Rogers, et al.. (2007). Prognostic Value of Transient and Sustained Increase in In-Hospital Creatinine on Outcomes of Patients Admitted With Acute Coronary Syndrome. The American Journal of Cardiology. 99(7). 939–942. 46 indexed citations
5.
Otten, Richard F., et al.. (2007). Brugada Syndrome in the Presence of Coronary Artery Disease and Parasympathomimetic Drug Therapy. Pacing and Clinical Electrophysiology. 30(8). 1039–1042. 2 indexed citations
7.
Ramanath, Vijay S., et al.. (2006). A quality guarantee in acute coronary syndromes: The American College of Cardiology's Guidelines Applied in Practice program taken real-time. American Heart Journal. 153(1). 16–21. 22 indexed citations
8.
Kline‐Rogers, Eva, Kim A. Eagle, Jianming Fang, et al.. (2005). Adherence to Medications by Patients After Acute Coronary Syndromes. Annals of Pharmacotherapy. 39(11). 1792–1797. 77 indexed citations
9.
Saab, Fadi, Kim A. Eagle, Eva Kline‐Rogers, et al.. (2004). Comparison of outcomes in acute coronary syndrome in patients receiving statins within 24 hours of onset versus at later times. The American Journal of Cardiology. 94(9). 1166–1168. 23 indexed citations
10.
Kline‐Rogers, Eva, Jianming Fang, Steven R. Erickson, et al.. (2004). 1153-70 Reasons for nonadherence to cardiac medications in patients discharged with acute coronary syndromes. Journal of the American College of Cardiology. 43(5). A417–A417. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026